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Abstract
Introduction N-terminal pro brain natriuretic peptide (NT-proBNP) is a cardiac biomarker that has
recently shown to be of diagnostic value in a diagnosis of decompensated heart failure, acute coronary
syndromes and other conditions resulting in myocardial stretch. We sought to study whether sepsis-
induced myocardial dilation would result in an elevation of NT-proBNP.
Method Serum NT-proBNP measurements were made in six consecutive patients with septic shock
within 6 hours of admission to the intensive care unit.
Results Markedly elevated levels of NT-proBNP were found in all six patients.
Conclusions NT-proBNP levels can be markedly elevated in critically ill patients presenting with septic
shock. An elevated NT-proBNP level in a critically ill patient is not specific for decompensated heart
failure.
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Introduction
Brain natriuretic peptide (BNP) is a hormone synthesized in
the ventricular myocardium. The stimulus for its release is
increased ventricular wall tension. Gene expression is the
main regulator of BNP secretion, and can increase very rapidly
in response to an appropriate stimulus. It is produced in the
prohormone form (proBNP), which before secretion by cardi-
omyocytes is split into the inactive 76-residue N-terminal frag-
ment (NT-proBNP) and the biologically active 32-residue C-
terminal fragment (BNP) [1].
BNP has been shown to be a useful cardiac biomarker for the
identification of patients with suspected heart failure [2]. Ele-
vated serum levels have also been described in left ventricular
systolic and diastolic dysfunction and right ventricular pres-
sure overload states such as pulmonary embolism, cor pulmo-
nale and primary pulmonary hypertension [3].
In a recent study by Witthaut and colleagues [4], both atrial
natriuretic peptide (ANP) and BNP were found to be signifi-
cantly elevated in patients with septic shock in comparison
with controls.
More recently, Charpentier and colleagues [5] made a similar
observation for BNP in patients with severe sepsis or septic
shock who had echocardiographic evidence of systolic myo-
cardial dysfunction.
A similar elevation of NT-proBNP in septic shock has, to our
knowledge, not been described before. We sought to study
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NT-proBNP because it had been found in the context of heart
failure to increase in concentration more strikingly and to have
better sensitivity and positive predictive value than BNP [6].
Methods
Patient population
We describe six patients admitted to the Medical Intensive
Care Unit (ICU) in our institution in July 2003 with septic
shock. None had a prior history of hypertension. Septic shock
was defined in accordance with the criteria of the consensus
conference of the American College of Chest Physicians and
Society of Critical Care Medicine [7]. Severity of disease was
quantified by the Acute Physiology and Chronic Health Evalu-
ation II (APACHE II) score [8].
Blood sampling and determination of NT-proBNP 
levels
All patients had blood samples taken for serum NT-proBNP
measurement within 6 hours of admission. Serum NT-proBNP
was determined with a sandwich immunoassay on an Elecsys
2010 (Roche Diagnostics, Mannheim, Germany). The analyti-
cal range extends from 20 ng l-1 to 35 µg l-1.
Ethics
Approval was obtained from our hospital's Institutional Review
Board.
Results
The clinical details of the six patients are summarized in Table
1. All were in septic shock requiring vasopressors. None had
pre-existing hypertension, ischemic heart disease or cor pul-
monale.
The initial hemodynamic profile of patient 1 is described in fur-
ther detail. After fluid resuscitation comprising 2.5 litres of col-
loids, the patient required intravenous dopamine (15 µg kg-1
min-1 to maintain a mean blood pressure of 70 mmHg. The car-
diac index was 3.06 l min-1 m-2. Intrathoracic blood volume
index (ITBVI) was 816 ml m-2 (normal range 850–1000 ml m-
2) and stroke volume index was 25 ml m-2 (normal range 40–
60 ml m-2). These hemodynamic data were measured with the
PiCCO® (Pulsion Medical Systems, Munich, Germany). The
data demonstrate no obvious excess of intravascular volume.
Discussion
Cardiac dysfunction is often present in patients with septic
shock. In a recent study by Charpentier and colleagues [5],
systolic myocardial dysfunction (as defined by a fractional area
contraction of less than 50% on echocardiography) was
present in 44% of a cohort of patients with severe sepsis or
septic shock, on the second day of their stay in the ICU. It is
now evident that myocardial depression has a clear role in sep-
tic shock. Septic myocardial depression is characterized by
reversible biventricular dilation, decreased systolic contractile
function, and decreased response to both resuscitation with
fluids and stimulation with catecholamines [9]. This myocardial
depression occurs in the presence of an overall hyperdynamic
circulation. This phenomenon is linked to the presence of a cir-
culating myocardial depressant factor, which is probably due
to tumour necrosis factor-α and interleukin-1β acting in syn-
ergy. These effects are mediated by mechanisms that include
the generation of nitric oxide and cyclic GMP [10].
Our results show clearly that NT-proBNP levels can be mark-
edly elevated in critically ill patients presenting with septic
Table 1
Clinical data for patients
Case Cause of septic shock Sex Age
(years)
APACHE 
II score
Vasopressor and 
dose
Mechanical 
ventilation
NT-proBNP 
(ng l-1)
TropT
(µg l-1)
CK (U l-1)C K - M B
(µg l-1)
Procalcito
nin (µg l-1)
Creatinine 
(µM)
1 Lung abscess Male 55 20 Dopamine
15µg kg -1 min-1 
Yes 4997 0.01 42 3 3.88 45
2 Acinetobacter 
baumanii pneumonia 
(bacteremic)
Female 62 32 Noradrenaline
2.0 µg kg-1 min -1
Yes 11,157 0.19 80 4 19.50 84
3 Leptospirosis Male 28 11 Dopamine
10 µg kg-1 min -1
No 6502 0.01 694 12 99.01 75
4 Escherichia coli 
pyelonephritis 
(bacteremic)
Female 59 8 Dopamine
10 µg kg-1 min-1
No 2163 0.01 278 3 26.71 80
5G a l l - b l a d d e r  
empyema
Female 75 40 Noradrenaline
0.7 µg kg-1 min -1
Yes 35,000 0.23 214 8 44.92 184
6 Escherichia coli 
pyelonephritis
Male 31 33 Noradrenaline
0.7 µg kg-1 min-1 + 
vasopressin 2 U h-1
Yes 35,000 0.15 440 4 28.76 329
APACHE II, Acute Physiology and Chronic Health Evaluation II; CK, creatine kinase; CK-MB, creatine kinase MB fraction; TropT, troponin T.Available online http://ccforum.com/content/8/4/R248
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shock. To our knowledge, our study is the first to describe this
observation. We postulate that this marked elevation of NT-
proBNP in our patients is a reflection of sepsis-induced ven-
tricular dilation. The important diagnostic implication of our
results is that an elevated NT-proBNP level in a critically ill
patient is not specific for decompensated heart failure.
The magnitude of elevation of NT-proBNP seen in our patients
was much greater than the twofold increase in BNP and four-
fold increase in ANP described by Witthaut and colleagues
[4]. This might be due to the longer half-life of NT-proBNP. NT-
proBNP might therefore be a more sensitive marker of septic
cardiomyopathy.
It remains to be seen whether the magnitude or trend of NT-
proBNP elevation in septic shock holds any prognostic value.
Further studies should be done to address this issue. What is
also unanswered at this time is which of the cardiac biomark-
ers – BNP, NT-proBNP or ANP – is the best biological marker
of myocardial dysfunction in patients with severe sepsis or
septic shock.
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Key messages
•  NT-proBNP elevations are seen in severe sepsis.
•  There are non-heart-failure causes of NT-proBNP ele-
vations in the ICU.